investments

The ARK Genomic Revolution ETF (ARKG,-2.2{791cf634350853aa929d899ac26203c48570d222f34b0095e87afe5e9b20c495}) NAV rose forty seven.seventy one{791cf634350853aa929d899ac26203c48570d222f34b0095e87afe5e9b20c495} in Q4, with market value rising 47.sixty one{791cf634350853aa929d899ac26203c48570d222f34b0095e87afe5e9b20c495}, the most effective performer of the actively managed funds. shares buck…